Depomed (DEPO) Receives U.S. FDA Notice of Allowance for Acuform Gastric Drug Delivery Tech
Tweet Send to a Friend
Depomed, Inc. (NASDAQ: DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
